Evidence map›Paper›PMID 37493833›Full record

ArticleEinstein (Sao Paulo, Brazil)2023

Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.

Muhammed Kızılgül, Ömer Bayır, Bekir Uçan, Pınar Akhanlı, Hakan Düğer, Muhammed Erkam Sencar, Hayri Kertmen, Demet Yılmazer, Doğan Yazılıtaş, Güleser Saylam and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Muhammed KızılgülDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8468-9196
Ömer BayırDepartment of Otorhinolaryngology and Head & Neck Surgery, University of Health Science, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-9445-6129
Bekir UçanDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-0810-5224
Pınar AkhanlıDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-1662-3363
Hakan DüğerDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5478-3192
Muhammed Erkam SencarDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5581-4886
Hayri KertmenDepartment of Neurosurgery, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-7113-9830
Demet YılmazerDepartment of Pathology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-1637-0415
Doğan YazılıtaşDepartment of Medical Oncology, University of Health Sciences, Dışkapı Yıldırım Beyazıt iskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0003-3850-7870
Güleser SaylamDepartment of Otorhinolaryngology and Head & Neck Surgery, University of Health Science, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6499-7140
Mehmet Hakan KorkmazDepartment of Otorhinolaryngology and Head & Neck Surgery, University of Health Science, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0001-8732-3061
Erman ÇakalDepartment of Endocrinology and Metabolism, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4455-7276
Sağlık Bilimleri Üniversitesi · TRUniversity of Health Science · KHMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this article, we present a case of diffuse follicular variant papillary thyroid carcinoma with pituitary metastasis, which is a rare cause of pituitary metastasis. The follicular variant of papillary thyroid carcinoma is an uncommon variant of papillary carcinoma. A 74-year-old male was presented with weakness, fatigue, and a decreased appetite. The patient was diagnosed with secondary adrenal and thyroid insufficiencies. Imaging revealed a pituitary mass with suprasellar extension, right cavernous sinus invasion, and optic chiasm compression. Thyroid ultrasonography revealed a nodule with a maximum size of 7.2cm in the right lobe. Cytological examination via fine-needle aspiration suggested papillary thyroid cancer. Total thyroidectomy with central and right lateral neck dissection confirmed the diagnosis of diffuse follicular variant of papillary thyroid carcinoma. Owing to visual field defects, the patient underwent transsphenoidal surgery. Histological and immunohistochemical evaluations confirmed pituitary metastasis from the papillary thyroid cancer. Radioactive iodine treatment and gamma knife radiotherapy of the pituitary gland were performed. The initiation of sorafenib treatment was deemed appropriate during the follow-up. A significant decrease in the thyroglobulin levels was observed after sorafenib treatment. Pituitary metastasis should be considered in patients diagnosed with hypopituitarism and pituitary lesions at initial evaluation. The presence of visual field defects may be an indication for neurosurgical intervention and guide both diagnosis and treatment. The management of papillary thyroid cancer and the role of treatment modalities in prognosis depend on the biological behavior of the tumor. Early diagnosis and multidisciplinary management are crucial for the treatment of these patients.

Indexed as

HypopituitarismThyroid NeoplasmsAgedHumansIodine RadioisotopesLymphatic MetastasisMaleSorafenibThyroid Cancer, PapillaryThyroidectomyIodine RadioisotopesSorafenib

Identifiers

PMID37493833
PMCPMC10356124
OpenAlexW4383426421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.